Literature DB >> 7625848

Analysis of an alternatively spliced exon of the neurofibromatosis type 1 gene in cultured melanocytes from patients with neurofibromatosis 1.

I Eisenbarth1, S Hoffmeyer, D Kaufmann, G Assum, W Krone.   

Abstract

Neurofibromatosis type 1 (NF1) is characterized by clinical features that primarily affect tissues derived from the neural crest (neurofibromas, café-aulait macules). Because aberrant regulation of alternative splicing in the NF1 gene transcript may be of functional significance, cultured melanocytes from café-aulait macules (CALM), as an example of benign NF1 lesions, were examined for the expression of the different alternative splice products of this gene. Both kinds of NF1 messengers (type 1 and 2) were found not only in CALM melanocytes but also in keratinocytes, fibroblasts and blood cells. Except in blood cells, there was a predominance of the type 2 transcript. Melanocytes from NF1 patients and healthy donors showed similar expression patterns under several culture conditions. Our results suggest that the development of CALM does not correlate with a switch in the ratio of type 1 to type 2 NF1 messenger RNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625848     DOI: 10.1007/bf00373420

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  16 in total

1.  A cell culture study on melanocytes from patients with neurofibromatosis-1.

Authors:  D Kaufmann; W Krone; R Hochsattel; R Martin
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 2.  Neurofibromatosis type 1 (NF1) gene: implication in neuroectodermal differentiation and genesis of brain tumors.

Authors:  T Nishi; H Saya
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

3.  Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation.

Authors:  T Nishi; P S Lee; K Oka; V A Levin; S Tanase; Y Morino; H Saya
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

4.  A small deletion and an adjacent base exchange in a potential stem-loop region of the neurofibromatosis 1 gene.

Authors:  M Stark; G Assum; W Krone
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

Review 5.  The neurofibromatosis type 1 gene and its protein product, neurofibromin.

Authors:  D H Gutmann; F S Collins
Journal:  Neuron       Date:  1993-03       Impact factor: 17.173

6.  The neurofibromatosis 1 gene transcripts expressed in peripheral nerve and neurofibromas bear the additional exon located in the GAP domain.

Authors:  C Teinturier; G Danglot; R Slim; D Pruliere; J M Launay; A Bernheim
Journal:  Biochem Biophys Res Commun       Date:  1992-10-30       Impact factor: 3.575

7.  Complete human NF1 cDNA sequence: two alternatively spliced mRNAs and absence of expression in a neuroblastoma line.

Authors:  A Bernards; V H Haase; A E Murthy; A Menon; G E Hannigan; J F Gusella
Journal:  DNA Cell Biol       Date:  1992-12       Impact factor: 3.311

8.  Regulated expression of the neurofibromin type I transcript in the developing chicken brain.

Authors:  L Baizer; G Ciment; S K Hendrickson; G L Schafer
Journal:  J Neurochem       Date:  1993-12       Impact factor: 5.372

9.  Melanin macroglobules as a cellular marker of neurofibromatosis: a quantitative study.

Authors:  R L Martuza; I Philippe; T B Fitzpatrick; J Zwaan; Y Seki; J Lederman
Journal:  J Invest Dermatol       Date:  1985-10       Impact factor: 8.551

10.  Neurofibromatosis of von Recklinghausen: a quantitative study of the epidermal keratinocyte and melanocyte populations.

Authors:  E Frenk; A Marazzi
Journal:  J Invest Dermatol       Date:  1984-07       Impact factor: 8.551

View more
  1 in total

1.  Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.

Authors:  Josep Biayna; Helena Mazuelas; Bernat Gel; Ernest Terribas; Gabrijela Dumbovic; Inma Rosas; Juana Fernández-Rodriguez; Ignacio Blanco; Elisabeth Castellanos; Meritxell Carrió; Conxi Lazaro; Eduard Serra
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.